Retention of CD4 + CD25 + FoxP3 + regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5323-5330

  Claassen, Mark A A ^a   de Knegt, Robert J ^a   Janssen, Harry L A ^a   Boonstra, André ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN; TRANSCRIPTION FACTOR FOXP3; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ASPIRATION BIOPSY; CD4+ CD25+ FOXP3+ REGULATORY T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ERADICATION THERAPY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOCYTE COUNT; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS LOAD;

ANTIGENS, CD4; ANTIVIRAL AGENTS; BIOPSY; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER; RIBAVIRIN; T-LYMPHOCYTES, REGULATORY;

HEPATITIS C VIRUS;

EID: 79956069393     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02551-10     Document Type: Article

References (24)

1. Boonstra, A., L. J. van der Laan, T. Vanwolleghem, and H. L. Janssen 2009. Experimental models for hepatitis C viral infection. Hepatology 50:1646-1655.
2. Burton, J. R., Jr., et al. 2008. Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. J. Hepatol. 49:329-338.
3. Claassen, M. A., R. J. de Knegt, H. W. Tilanus, H. L. Janssen, and A. Boonstra 2010. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J. Hepatol. 52:315-321.
4. Crispe, I. N. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27:147-163.
5. Dustin, L. B., and C. M. Rice 2007. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25:71-79.
6. Feld, J. J., and J. H. Hoofnagle 2005. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436:967-972.
7. Freeman, A. J., G. Marinos, R. A. Ffrench, and A. R. Lloyd 2005. Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-alpha and ribavirin treatment among patients with chronic hepatitis C virus infection. J. Viral Hepat. 12:125-129.
8. Korn, T., et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13:423-431.
9. Lohr, H. F., et al. 1999. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies. J. Hepatol. 31:407-415.
10. Ma, X., et al. 2007. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46:1519-1529.
11. Miyaaki, H., et al. 2009. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients. Liver Int. 29:702-707.
12. Nelson, D. R., C. G. Marousis, T. Ohno, G. L. Davis, and J. Y. Lau 1998. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 28: 225-230.
13. Penton-Rol, G., et al. 2008. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients. Int. Immunopharmacol. 8:881-886.
14. Pilli, M., et al. 2007. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 133:1132-1143.
15. Rehermann, B., and M. Nascimbeni 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5:215-229.
16. Roncarolo, M. G., and S. Gregori 2008. Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 38:925-927.
17. Rosen, H. R., et al. 2007. Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy. Hepatology 46:350-358.
18. Sakaki, M., et al. 2008. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol. Res. 38:354-361.
19. Sarasin-Filipowicz, M., J. Krol, I. Markiewicz, M. H. Heim, and W. Filipowicz 2009. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15:31-33.
20. Shoukry, N. H., A. G. Cawthon, and C. M. Walker 2004. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58:391-424.
21. Sprengers, D., et al. 2005. Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis. J. Viral Hepat. 12:507-512.
22. Stoop, J. N., et al. 2008. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin. Immunol. 129:419-427.
23. Veerapu, N. S., S. Raghuraman, T. J. Liang, T. Heller, and B. Rehermann 2011. Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. Gastroenterology 140:676-685, e671.
24. Ward, S. M., et al. 2007. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J. Hepatol. 47:316-324.